These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 15042278

  • 1. Effects of serotonergic and noradrenergic antidepressants on auditory startle response in patients with major depression.
    Quednow BB, Kühn KU, Stelzenmuelle R, Hoenig K, Maier W, Wagner M.
    Psychopharmacology (Berl); 2004 Oct; 175(4):399-406. PubMed ID: 15042278
    [Abstract] [Full Text] [Related]

  • 2. Differential prediction of first clinical response to serotonergic and noradrenergic antidepressants using the loudness dependence of auditory evoked potentials in patients with major depressive disorder.
    Juckel G, Pogarell O, Augustin H, Mulert C, Müller-Siecheneder F, Frodl T, Mavrogiorgou P, Hegerl U.
    J Clin Psychiatry; 2007 Aug; 68(8):1206-12. PubMed ID: 17854244
    [Abstract] [Full Text] [Related]

  • 3. Are there differences between serotonergic, noradrenergic and dual acting antidepressants in the treatment of depressed women?
    Eker SS, Kirli S, Akkaya C, Cangur S, Sarandol A.
    World J Biol Psychiatry; 2009 Aug; 10(4 Pt 2):400-8. PubMed ID: 19670086
    [Abstract] [Full Text] [Related]

  • 4. Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin.
    Liechti ME, Geyer MA, Hell D, Vollenweider FX.
    Neuropsychopharmacology; 2001 Mar; 24(3):240-52. PubMed ID: 11166515
    [Abstract] [Full Text] [Related]

  • 5. Basal prolactin values correlate with response to reboxetine treatment in major depression, but not with response to citalopram.
    Moeller O, Hetzel G, Michael N, Rothermundt M, Arolt V, Erfurth A.
    Neuropsychobiology; 2005 Mar; 51(2):67-71. PubMed ID: 15741746
    [Abstract] [Full Text] [Related]

  • 6. The effects of imipramine on P50 suppression, prepulse inhibition and habituation of the startle response in humans.
    Hammer TB, Oranje B, Glenthoj BY.
    Int J Neuropsychopharmacol; 2007 Dec; 10(6):787-95. PubMed ID: 17250777
    [Abstract] [Full Text] [Related]

  • 7. The impact of the selective monoamine reuptake inhibitors reboxetine and citalopram on visually-evoked event-related potentials in depressed patients.
    Hetzel G, Moeller O, Erfurth A, Michael N, Rothermundt M, Arolt V, Evers S.
    Pharmacopsychiatry; 2004 Sep; 37(5):200-5. PubMed ID: 15470798
    [Abstract] [Full Text] [Related]

  • 8. Effects of various antidepressants on serum thyroid hormone levels in patients with major depressive disorder.
    Eker SS, Akkaya C, Sarandol A, Cangur S, Sarandol E, Kirli S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May 15; 32(4):955-61. PubMed ID: 18262705
    [Abstract] [Full Text] [Related]

  • 9. Noradrenaline-selective versus serotonin-selective antidepressant therapy: differential effects on social functioning.
    Dubini A, Bosc M, Polin V.
    J Psychopharmacol; 1997 May 15; 11(4 Suppl):S17-23. PubMed ID: 9438229
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the effectiveness of reboxetine versus fluoxetine in patients with atypical depression: a single-blind, randomized clinical trial.
    Taner E, Demir EY, Cosar B.
    Adv Ther; 2006 May 15; 23(6):974-87. PubMed ID: 17276965
    [Abstract] [Full Text] [Related]

  • 11. A comparison of the efficacy and tolerability of reboxetine and sertraline versus venlafaxine in major depressive disorder: a randomized, open-labeled clinical trial.
    Yazicioglu B, Akkaya C, Sarandol A, Akgoz S, Saygin Eker S, Kirli S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep 30; 30(7):1271-6. PubMed ID: 16820257
    [Abstract] [Full Text] [Related]

  • 12. The effects of increased central serotonergic activity on prepulse inhibition and habituation of the human startle response.
    Jensen KS, Oranje B, Wienberg M, Glenthøj BY.
    Neuropsychopharmacology; 2007 Oct 30; 32(10):2117-24. PubMed ID: 17299503
    [Abstract] [Full Text] [Related]

  • 13. Noradrenergic approaches to antidepressant therapy.
    Gorman JM, Sullivan G.
    J Clin Psychiatry; 2000 Oct 30; 61 Suppl 1():13-6. PubMed ID: 10703758
    [Abstract] [Full Text] [Related]

  • 14. Functional effects of agents differentially selective to noradrenergic or serotonergic systems.
    Tranter R, Healy H, Cattell D, Healy D.
    Psychol Med; 2002 Apr 30; 32(3):517-24. PubMed ID: 11989996
    [Abstract] [Full Text] [Related]

  • 15. Treatment effects of serotonergic and noradrenergic antidepressants on the intensity dependence of auditory ERP components in major depression.
    Linka T, Sartory G, Wiltfang J, Müller BW.
    Neurosci Lett; 2009 Sep 29; 463(1):26-30. PubMed ID: 19616062
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Reboxetine, a new noradrenaline selective antidepressant, is at least as effective as fluoxetine in the treatment of depression.
    Andreoli V, Caillard V, Deo RS, Rybakowski JK, Versiani M.
    J Clin Psychopharmacol; 2002 Aug 29; 22(4):393-9. PubMed ID: 12172339
    [Abstract] [Full Text] [Related]

  • 18. Successful management of depression with reboxetine in a patient who developed Parkinsonism related to paroxetine use.
    Kuloglu M, Caykoylu A, Ekinci O, Bayindirli D, Vural G, Deniz O.
    J Psychopharmacol; 2010 Apr 29; 24(4):623-4. PubMed ID: 19074535
    [No Abstract] [Full Text] [Related]

  • 19. Different gender response to serotonergic and noradrenergic antidepressants. A comparative study of the efficacy of citalopram and reboxetine.
    Berlanga C, Flores-Ramos M.
    J Affect Disord; 2006 Oct 29; 95(1-3):119-23. PubMed ID: 16782204
    [Abstract] [Full Text] [Related]

  • 20. Randomized double-blind comparison of serotonergic (Citalopram) versus noradrenergic (Reboxetine) reuptake inhibitors in outpatients with somatoform, DSM-IV-TR pain disorder.
    Aragona M, Bancheri L, Perinelli D, Tarsitani L, Pizzimenti A, Conte A, Inghilleri M.
    Eur J Pain; 2005 Feb 29; 9(1):33-8. PubMed ID: 15629872
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.